Cataract and Prostate Cancer Treatment

Baltimore Washington Eye Center, Maryland

Friday, August 26, 2011

Cataract & Prostate Cancer Treatment

Researchers reporting in the Annals of Epidemiology (November 2010) concluded that the risk of developing Cataracts may be higher in patients being treated for prostate cancer with Androgen Deprivation Therapy (ADT). The side effects of ADT such as weight gain, insulin resistance and blood lipid level problems have been linked to Cataract formation. Although further prospective study is necessary to truly understand the findings, researchers from Karmanos Cancer Institute in Detroit used the Surveillance, Epidemiology and End Results Medicare database to analyze cataract formation in prostate cancer patients.